Akebia Therapeutics Inc. (AKBA)
NASDAQ · Healthcare
Akebia Therapeutics Inc. Net Income 2014–2025
Akebia Therapeutics Inc. annual/quarterly net income history and growth rate from 2014 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Akebia Therapeutics Inc. net income for the quarter ending March 31, 2026 was -9.1 M, a 248.13% decrease year-over-year.
- Akebia Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -2.2 M, a 96.47% decrease year-over-year.
- Akebia Therapeutics Inc. annual net income for 2025 was -5.3 M, a 92.30% decrease from 2024.
- Akebia Therapeutics Inc. annual net income for 2024 was -69.4 M, a 33.67% increase from 2023.
- Akebia Therapeutics Inc. annual net income for 2023 was -51.9 M, a 44.89% decrease from 2022.
- Akebia Therapeutics Inc. annual net income for 2022 was -94.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Akebia Therapeutics Inc. Net Income — FAQ
Akebia Therapeutics Inc. (AKBA) net income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Akebia Therapeutics Inc.'s net income?
Akebia Therapeutics Inc. (AKBA) reported net income of -$5M for fiscal 2025.
Where can I see AKBA's net income history?
The chart and table above show Akebia Therapeutics Inc.'s net income by year and by quarter, including the growth rate.